Interview with Ales Tichopad, General Director, CEEROR
Mr. Tichopad, can you please begin by introducing yourself and your company to our readers? My background is in bio-statistics. I am a biologist by education, and in the beginning…
Omega Pharma is a dynamic organization specialized in developing, manufacturing and sale of medical devices, food supplements and medical cosmetics as on the OTC pharmaceutical market as in wide distribution on the mass-market. It is part of the multinational group Omega Pharma which is headquartered in Belgium and present in 40 countries.
High specialization, professionalism and superior customer service have enabled a dynamic development of the company and it has been included among the major players on the market.
From the very beginning, Omega Pharma has been a marketing-driven company with a strong focus on customer’s needs, requirements and resulting satisfaction. It holds many patents and applies unique solutions to high-efficiency products in product lines.
The company now has its own Development Center of Excellence. In terms of research and its application we interact with renowned centers in the Czech Republic and across Europe.
The products registered at the Industrial Property Rights in Czech Republic come from our own research laboratory. We participate in research and development of the products with guaranteed support of the state organizations and our priorities include not only development but also responsible clinical testing of each product prior to launching it into the market.
Contact
OMEGA PHARMA A.S.
Drážní 253/7
Brno 62700
+420 800 400 113
Mr. Tichopad, can you please begin by introducing yourself and your company to our readers? My background is in bio-statistics. I am a biologist by education, and in the beginning…
Mr. Kužela, you have a very interesting background: from 1993 until 2011, you variously worked for the Staropramen beer factory and its parent organization, StarBev. You identify yourself as an…
You joined this affiliate in October of 2011, having spent the preceding three years as GM for Servier Slovakia. What are the principal differences you found between these two markets?…
Dr. Novotný, in 2008, you became Managing Director for MSD for the Czech and Slovak Republics. In the very next year after your appointment, you were tasked with managing the…
Dr. Heger, you were appointed as the Czech Minister of Health in July of 2010. What challenges did you see for the Czech healthcare system, and what has been your…
Mr. Krýza, Mr. Nádvorník, between the two of you, you have over 21 years of experience at Cegedim, and have watched this company grow significantly through a series of mergers.…
Mr. Krýza, Mr. Nádvorník, between the two of you, you have over 21 years of experience at Cegedim, and have watched this company grow significantly through a series of mergers.…
Ms. Hauser, you represent what is perhaps the last major generation of medical doctors in this country that left the medical field to join the pharmaceutical business. What do you…
Mr. Krejčí, can you please begin with a broad introduction to Ewopharma, for those of our readers who are unfamiliar with the company? Ewopharma is part of a large group…
Mr. Zahradnik, you have long been an active member of the Czech generic drug makers’ association CAFF (Czech Association of Pharmaceutical Firms), chairing the organization. Dr. Zörner, executive director of…
Mr. Polach, can you please begin with an introduction to CzechBio and explicate the association’s mission on this market? CzechBio is an association of Czech biotech companies that started its…
Mr. Chadim, after Astellas was formed from the merger between Yamanouchi and Fujisawa, it became your job to lead its Czech subsidiary. Tapani Sura, your colleague at Astellas Poland, has…
See our Cookie Privacy Policy Here
